Kashinath Gangadhara Yadalam MD

Psychiatry•Lake Charles, LA

Lake Charles Clinical Trials is a dedicated psychiatric research facility with a staff of 15.

Join to View Full Profile

1 Lakeshore DrSuite 1695Lake Charles, LA 70629
Phone+1 337-564-6405
Fax+1 337-656-2563

Education & Training

University of Nebraska Medical Center College of MedicineResidency, Psychiatry, 1980 - 1983
Kasturba Medical College ManipalClass of 1978

Certifications & Licensure

LA State Medical License 1991 - 2025
TX State Medical License 1992 - 2024
FL State Medical License 1991 - 2006
PA State Medical License 1983 - 1994
WA State Medical License 1990 - 1993
IA State Medical License 1982 - 1984
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Start of enrollment: 2011 Feb 01
Completed
Phase 2, Phase 3
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
Completed
Phase 3
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

25 citations
Fluphenazine plasma levels, dosage, efficacy, and side effects.
Douglas F. Levinson, GeorgeM. Simpson, Ee Sing Lo, ThomasB. Cooper, Hardeep Singh
The American Journal of Psychiatry. 1995-05-01
15 citations
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
George M. Simpson, Kashinath G. Yadalam, Douglas F. Levinson, Mary Jeanne Stephanos, Ee Sing Lo
Journal of Clinical Psychopharmacology. 1990-12-01
63 citations
Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment.
Douglas F. Levinson, George M. Simpson, Hardeep Singh, Kashinath G. Yadalam, Anil K Jain
Archives of General Psychiatry. 1990-08-01

Grant Support

Computed Tomographic Study Of SchizophreniaNational Institute Of Mental Health1987–1989

Other Languages

Telugu